Relationship Between Severity of Adverse Events of Afatinib and Its Pharmacokinetics and Pharmacogenomics for EGFR Mutation-Positive Non-Small Cell Lung Cancer

T. Gomyo,H. Iihara,H. Hayashi,J. Endo, F. Ito, K. Yansase,D. Kaito, Y. Sasaki,C. Sakai, Y. Fukuda,C. Hirose,T. Sugiyama,A. Suzuki,Y. Ohno

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE（2019）

引用 0|浏览65

暂无评分

关键词

cell lung cancer,lung cancer,pharmacogenomics,mutation-positive,non-small

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要